The hidden epidemic of post-tuberculosis bronchiectasis
Article Sidebar
Main Article Content
Abstract
-
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Titus G, Hassanali S, Feldman C. Non-cystic fibrosis bronchiectasis: A single-centre retrospective study in Johannesburg, South Africa. Afr J Thorac Crit Care Med 2023;29(4):e1017. https://doi.org/10.7196/AJTCCM.2023.v29i4.1017
O’Donnell AE. Bronchiectasis – a clinical review. N Engl J Med 2022;387(6):533-545.
https://doi.org/10.1056/NEJMra2202819
Quint JK, Millett ERC, Joshi M, et al. Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: A population-based cohort study. Eur Respir J 2016;47(1):186-193. https://doi.org/10.1183/13993003.01033-2015
Weycker D, Hansen GL, Seifer FD. Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013. Chron Respir Dis 2017;14(4):377-384. https://doi.org/10.1177/1479972317709649
Monteagudo M, Rodríguez-Blanco T, Barrecheguren M, Simonet P, Miravitlles M. Prevalence and incidence of bronchiectasis in Catalonia, Spain: A population-based study. Respir Med 2016;121:26-31. https://doi.org/10.1016/j.rmed.2016.10.014
Phua HP, Lim WY, Ganesan G, et al. Epidemiology and economic burden of bronchiectasis requiring hospitalisation in Singapore. ERJ Open Res 2021;7(4):00334- 2021. https://doi.org/10.1183/23120541.00334-2021
RingshausenFC,deRouxA,DielR,HohmannD,WelteT,RademacherJ.Bronchiectasis in Germany: A population-based estimation of disease prevalence. Eur Respir J 2015;46(6):1805-1807. https://doi.org/10.1183/13993003.00954-2015
Lin JL, Xu JF, Qu JM. Bronchiectasis in China. Ann Am Thorac Soc 2016;13(5):609-616.
https://doi.org/10.1513/AnnalsATS.201511-740PS
Gao YH, Guan WJ, Liu SX, et al. Aetiology of bronchiectasis in adults: A systematic literature review. Respirology 2016;21(8):1376-1383. https://doi.org/10.1111/resp.12832
Dhar R, Singh S, Talwar D, et al. Bronchiectasis in India: Results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry. Lancet Glob Health 2019;7(9):e1269-e1279. https:// doi.org/10.1016/S2214-109X(19)30327-4
HogerS,LykensK,BeaversSF,KatzD,MillerTL.Longevitylossamongcuredtuberculosis patients and the potential value of prevention. Int J Tuberc Lung Dis 2014;18(11):1347- 1352. https://doi.org/10.5588/ijtld.14.0242
Tocque K, Convrey RP, Bellis MA, Beeching NJ, Davies PD. Elevated mortality following diagnosis with a treatable disease: Tuberculosis. Int J Tuberc Lung Dis 2005;9(7):797-802. 13. Romanowski K, Baumann B, Basham CA, Ahmad Khan F, Fox GJ, Johnston JC. Long- term all-cause mortality in people treated for tuberculosis: A systematic review and meta-analysis. Lancet Infect Dis 2019;19(10):1129-1137. https://doi.org/10.1016/S1473-
(19)30309-3
SalkinD.Tuberculosisasacauseofupperlobebronchiectasis.CalifMed1950;73(6):577- 580.
Meghji J, Lesosky M, Joekes E, et al. Patient outcomes associated with post-tuberculosis lung damage in Malawi: A prospective cohort study. Thorax 2020;75(3):269-278. https:// doi.org/10.1136/thoraxjnl-2019-213808
World Health Organization. Global Tuberculosis Report 2022. Geneva: WHO, 2022.
https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-
tuberculosis-report-2022 (accessed 13 November 2023).
Goolam Mahomed A, Maasdorp SD, Barnes R, et al. South African Thoracic Society
position statement on the management of non-cystic fibrosis bronchiectasis in adults: 2023. Afr J Thorac Crit Care Med 2023;29(2):e647. https://doi.org/10.7196/ AJTCCM.2023.v29i2.647
Håkansson KEJ, Fjaellegaard K, Browatzki A, Dönmez Sin MD, Ulrik CS. Inhaled corticosteroid therapy in bronchiectasis is associated with all-cause mortality: A rospective cohort study. Int J Chron Obstruct Pulmon Dis 2021;16:2119-2127. https:// doi.org/10.2147/COPD.S311236
Brode SK, Campitelli MA, Kwong JC, et al. The risk of mycobacterial infections associated with inhaled corticosteroid use. Eur Respir J 2017;50(3):1700037. https://doi. org/10.1183/13993003.00037-2017
Van der Veer T, de Koning Gans JM, Braunstahl GJ, et al. The effect of beclomethasone- formoterol versus placebo on chronic cough in patients with non-CF bronchiectasis: The FORZA randomised controlled trial. Eur Respir J 2023;61(6):2300186. https://doi. org/10.1183/13993003.00186-2023